Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen M Shore

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
Expert Opinion on Biological Therapy|May 5, 2007
A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeletonFrederick S Kaplan, David L Glaser, Robert J Pignolo, et al.
Bone|January 9, 2018
Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafishBettina E Mucha, Megumi Hashiguchi, Joseph Zinski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2019
Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for OsteogenesisAlexandra Stanley, Su-Jin Heo, Robert L Mauck, et al.
Expert Opinion on Orphan Drugs|November 28, 2017
Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)Frederick S Kaplan, Robert J Pignolo, Mona M Al Mukaddam, et al.
The Journal of Bone and Joint Surgery. American Volume|April 4, 2003
Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesisJaimo Ahn, Lourdes Serrano de la Pena, Eileen M Shore, et al.
Annals of the New York Academy of Sciences|November 16, 2011
Fibrodysplasia ossificans progressiva: a blueprint for metamorphosisFrederick S Kaplan, Vitali Y Lounev, Haitao Wang, et al.
The Application of Clinical Genetics|February 13, 2015
Progressive osseous heteroplasia: diagnosis, treatment, and prognosisRobert J Pignolo, Girish Ramaswamy, John T Fong, et al.
Current Osteoporosis Reports|February 18, 2015
The immunological contribution to heterotopic ossification disordersMichael R Convente, Haitao Wang, Robert J Pignolo, et al.
Bone|July 31, 2020
Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesisFrederick S Kaplan, Mona Al Mukaddam, Alexandra Stanley, et al.
NPJ Regenerative Medicine|January 15, 2022
Dynamics of skeletal muscle-resident stem cells during myogenesis in fibrodysplasia ossificans progressivaAlexandra Stanley, Elisia D Tichy, Jacob Kocan, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Expert Opinion on Biological Therapy|May 5, 2007
A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeletonFrederick S Kaplan, David L Glaser, Robert J Pignolo, et al.
Bone|January 9, 2018
Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafishBettina E Mucha, Megumi Hashiguchi, Joseph Zinski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2019
Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for OsteogenesisAlexandra Stanley, Su-Jin Heo, Robert L Mauck, et al.
Expert Opinion on Orphan Drugs|November 28, 2017
Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)Frederick S Kaplan, Robert J Pignolo, Mona M Al Mukaddam, et al.
The Journal of Bone and Joint Surgery. American Volume|April 4, 2003
Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesisJaimo Ahn, Lourdes Serrano de la Pena, Eileen M Shore, et al.
Annals of the New York Academy of Sciences|November 16, 2011
Fibrodysplasia ossificans progressiva: a blueprint for metamorphosisFrederick S Kaplan, Vitali Y Lounev, Haitao Wang, et al.
The Application of Clinical Genetics|February 13, 2015
Progressive osseous heteroplasia: diagnosis, treatment, and prognosisRobert J Pignolo, Girish Ramaswamy, John T Fong, et al.
Current Osteoporosis Reports|February 18, 2015
The immunological contribution to heterotopic ossification disordersMichael R Convente, Haitao Wang, Robert J Pignolo, et al.
Bone|July 31, 2020
Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesisFrederick S Kaplan, Mona Al Mukaddam, Alexandra Stanley, et al.
NPJ Regenerative Medicine|January 15, 2022
Dynamics of skeletal muscle-resident stem cells during myogenesis in fibrodysplasia ossificans progressivaAlexandra Stanley, Elisia D Tichy, Jacob Kocan, et al.
Pageof 14